You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 87 No. 2, February 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Therapy in Experimental Hyphema

II. Acetazolamide

Samuel Masket, MD; Milton Best, MD

Arch Ophthalmol. 1972;87(2):222-224.


Abstract

The effect of acetazolamide on the rate of absorption of clotted hyphemas in rabbits was studied by a radioactive assay technique. The results indicate that acetazolamide, administered intravenously once or twice daily, reduced intraocular pressure but does not enhance hyphema resorption. Hypotony and decreased aqueous secretion do not appear to play an important role in resorption of hyphemas.



Author Affiliations

New York

From the Department of Ophthalmology, New York Medical College, Center for Chronic Disease, Bird S. Coler Hospital, Welfare Island, New York.


Footnotes

Submitted for publication June 24, 1971.

Reprint requests to Bird S. Coler Hospital, Welfare Island, New York 10017 (Dr. Best).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Experimental Hyphema Clearance in Rabbits: Drug Trials With 1% Atropine and 2% and 4% Pilocarpine
Rose et al.
Arch Ophthalmol 1977;95:1442-1444.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.